{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:11:27Z","timestamp":1790730687080,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Program of Chongqing Clinical Medical Research","award":["NCRCCHD-2021-KP-03"],"award-info":[{"award-number":["NCRCCHD-2021-KP-03"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Sepsis is a severe condition characterized by acute organ dysfunction resulting from an imbalanced host immune response to infections. Apolipoprotein H (APOH) is a critical plasma protein that plays a crucial role in regulating various biological processes. However, the precise role of APOH in the immunopathology of paediatric sepsis remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we evaluated the concentration of APOH in paediatric patients with sepsis and healthy individuals. In an experimental sepsis model of caecal ligation and puncture\u00a0(CLP), the impact of APOH on survival, organ injury, and inflammation was measured. Furthermore, the anti-inflammatory effects of APOH were investigated across diverse immune cell types, encompassing peripheral blood mononuclear cells (PBMCs), peritoneal macrophages (PMs), bone marrow-derived macrophages (BMDMs), and RAW 264.7 macrophages.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the pilot cohort, the relative abundance of APOH was found to be decreased in patients with sepsis (2.94\u2009\u00b1\u20090.61) compared to healthy controls (1.13\u2009\u00b1\u20090.84) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), non-survivors had lower levels of APOH (0.50\u2009\u00b1\u20090.37) compared to survivors (1.45\u2009\u00b1\u20090.83) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). In the validation cohort, the serum concentration of APOH was significantly decreased in patients with sepsis (202.0\u2009\u00b1\u200922.5\u00a0ng\/ml) compared to healthy controls (409.5\u2009\u00b1\u2009182.9\u00a0ng\/ml) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). The application of recombinant APOH protein as a therapeutic intervention significantly lowered the mortality rate, mitigated organ injury, and suppressed inflammation in mice with severe sepsis. In contrast, neutralizing APOH with an anti-APOH monoclonal antibody increased the mortality rate, exacerbated organ injury, and intensified inflammation in mice with non-severe sepsis. Intriguingly, APOH exhibited minimal effects on the bacterial burden, neutrophil, and macrophage counts in the sepsis mouse model, along with negligible effects on bacterial phagocytosis and killing during\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      infection in PMs, RAW 264.7 cells, and PBMCs. Mechanistic investigations in PMs and RAW 264.7 cells revealed that APOH inhibited M1 polarization in macrophages by suppressing toll-like receptor 4 (TLR4)\/nuclear factor-\u03baB (NF-\u03baB) signalling pathway.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This proof-of-concept study demonstrated that APOH has a protective role in the host defense response to sepsis, highlighting the potential therapeutic value of APOH in sepsis treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13054-024-04809-2","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T05:03:07Z","timestamp":1706590987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["The protective effect of apolipoprotein H in paediatric sepsis"],"prefix":"10.1186","volume":"28","author":[{"given":"Zhicai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxue","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Pi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bian","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1651-591X","authenticated-orcid":false,"given":"Zhen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"issue":"8","key":"4809_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801\u201310.","journal-title":"JAMA"},{"issue":"1","key":"4809_CR2","first-page":"56","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"issue":"1","key":"4809_CR3","first-page":"74","volume":"9","author":"F Pei","year":"2022","unstructured":"Pei F, Yao RQ, Ren C, Bahrami S, Billiar TR, Chaudry IH, et al. Expert consensus on the monitoring and treatment of sepsis-induced immunosuppression. Mil Med Res. 2022;9(1):74.","journal-title":"Mil Med Res"},{"issue":"10219","key":"4809_CR4","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"KE Rudd","year":"2020","unstructured":"Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Kievlan DR, et al. Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet (London, England). 2020;395(10219):200\u201311.","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4809_CR5","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s11926-010-0151-9","volume":"13","author":"B Giannakopoulos","year":"2011","unstructured":"Giannakopoulos B, Mirarabshahi P, Krilis SA. New insights into the biology and pathobiology of beta2-glycoprotein I. Curr Rheumatol Rep. 2011;13(1):90\u20135.","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"4809_CR6","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1016\/j.jvs.2014.05.096","volume":"62","author":"J De Haro","year":"2015","unstructured":"De Haro J, Esparza L, Bleda S, Varela C, Sanchez C, Acin F. Attenuation of early atherosclerotic lesions by immunotolerance with \u03b22 glycoprotein I and the immunomodulatory effectors interleukin 2 and 10 in a murine model. J Vasc Surg. 2015;62(6):1625\u201331.","journal-title":"J Vasc Surg"},{"key":"4809_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1471-2261-14-114","volume":"14","author":"J Xu","year":"2014","unstructured":"Xu J, Wang P, Wang T, Wang M, Chen S, Yu P, et al. Effects of reduced \u03b22-glycoprotein I on the expression of aortic matrix metalloproteinases and tissue inhibitor matrix metalloproteinases in diabetic mice. BMC Cardiovasc Disord. 2014;14:114.","journal-title":"BMC Cardiovasc Disord"},{"issue":"5","key":"4809_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1055\/s-0037-1601329","volume":"44","author":"H Kelchtermans","year":"2018","unstructured":"Kelchtermans H, Chayou\u00e2 W, Laat B. The significance of antibodies against domain I of beta-2 glycoprotein I in antiphospholipid syndrome. Semin Thromb Hemost. 2018;44(5):458\u201365.","journal-title":"Semin Thromb Hemost"},{"issue":"25","key":"4809_CR9","doi-asserted-by":"publisher","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","volume":"117","author":"C Agar","year":"2011","unstructured":"Agar C, de Groot PG, M\u00f6rgelin M, Monk SD, van Os G, Levels JH, et al. \u03b22-glycoprotein I: a novel component of innate immunity. Blood. 2011;117(25):6939\u201347.","journal-title":"Blood"},{"issue":"1","key":"4809_CR10","doi-asserted-by":"publisher","first-page":"8201","DOI":"10.1038\/s41598-017-07945-8","volume":"7","author":"F El-Assaad","year":"2017","unstructured":"El-Assaad F, Qi M, Gordon AK, Qi J, Dong S, Passam F, et al. \u0392eta 2-glycoprotein I protects mice against gram-negative septicaemia in a sexually dimorphic manner. Sci Rep. 2017;7(1):8201.","journal-title":"Sci Rep"},{"issue":"1","key":"4809_CR11","first-page":"2","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2005;6(1):2\u20138.","journal-title":"Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc"},{"issue":"4","key":"4809_CR12","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1097\/CCM.0000000000005335","volume":"50","author":"X Yu","year":"2022","unstructured":"Yu X, Chen J, Tang H, Tu Q, Li Y, Yuan X, et al. Identifying prokineticin2 as a novel immunomodulatory factor in diagnosis and treatment of sepsis. Crit Care Med. 2022;50(4):674\u201384.","journal-title":"Crit Care Med"},{"issue":"8","key":"4809_CR13","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00812-20","volume":"89","author":"M Shamaei","year":"2021","unstructured":"Shamaei M, Mirsaeidi M. Nontuberculous mycobacteria, macrophages, and host innate immune response. Infect Immun. 2021;89(8): e0081220.","journal-title":"Infect Immun"},{"issue":"9","key":"4809_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024827","volume":"6","author":"G Subbiahdoss","year":"2011","unstructured":"Subbiahdoss G, Fern\u00e1ndez IC, Domingues JF, Kuijer R, van der Mei HC, Busscher HJ. In vitro interactions between bacteria, osteoblast-like cells and macrophages in the pathogenesis of biomaterial-associated infections. PLoS ONE. 2011;6(9): e24827.","journal-title":"PLoS ONE"},{"issue":"5","key":"4809_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2022.5120","volume":"49","author":"J Luo","year":"2022","unstructured":"Luo J, Zhang M, Wang Z, Yan L, Liu Y. Anti-\u03b2(2)GPI\/\u03b2(2)GPI induces neutrophil pyroptosis and thereby enhances ICAM-1 and IL-8 expression in endothelial cells. Int J Mol Med. 2022;49(5):1\u201312.","journal-title":"Int J Mol Med"},{"issue":"12","key":"4809_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0278708","volume":"17","author":"A Ruiz-Sanmart\u00edn","year":"2022","unstructured":"Ruiz-Sanmart\u00edn A, Ribas V, Su\u00f1ol D, Chiscano-Cam\u00f3n L, Palmada C, Baja\u00f1a I, et al. Characterization of a proteomic profile associated with organ dysfunction and mortality of sepsis and septic shock. PLoS ONE. 2022;17(12): e0278708.","journal-title":"PLoS ONE"},{"issue":"1","key":"4809_CR17","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s13054-020-03066-3","volume":"24","author":"IT Schrijver","year":"2020","unstructured":"Schrijver IT, Kemperman H, Roest M, Kesecioglu J, de Lange DW. Beta-2-glycoprotein I as a biomarker for sepsis in critically ill patients in the intensive care unit: a prospective cohort study. Crit Care (London, England). 2020;24(1):341.","journal-title":"Crit Care (London, England)"},{"key":"4809_CR18","doi-asserted-by":"publisher","first-page":"33656","DOI":"10.1038\/srep33656","volume":"6","author":"S Zhou","year":"2016","unstructured":"Zhou S, Chen G, Qi M, El-Assaad F, Wang Y, Dong S, et al. Gram negative bacterial inflammation ameliorated by the plasma protein beta 2-glycoprotein I. Sci Rep. 2016;6:33656.","journal-title":"Sci Rep"},{"issue":"12","key":"4809_CR19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.4049\/immunohorizons.2100086","volume":"5","author":"DG Goswami","year":"2021","unstructured":"Goswami DG, Rubio AJ, Mata J, Munoz S, Gallegos A, Walker WE. Large peritoneal macrophages and transitional premonocytes promote survival during abdominal sepsis. ImmunoHorizons. 2021;5(12):994\u20131007.","journal-title":"ImmunoHorizons"},{"issue":"11","key":"4809_CR20","doi-asserted-by":"publisher","first-page":"5858","DOI":"10.1172\/JCI130996","volume":"130","author":"D Patoli","year":"2020","unstructured":"Patoli D, Mignotte F, Deckert V, Dusuel A, Dumont A, Rieu A, et al. Inhibition of mitophagy drives macrophage activation and antibacterial defense during sepsis. J Clin Investig. 2020;130(11):5858\u201374.","journal-title":"J Clin Investig"},{"issue":"3","key":"4809_CR21","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/j.1365-2958.2007.05974.x","volume":"67","author":"M Nilsson","year":"2008","unstructured":"Nilsson M, Wasylik S, M\u00f6rgelin M, Olin AI, Meijers JC, Derksen RH, et al. The antibacterial activity of peptides derived from human beta-2 glycoprotein I is inhibited by protein H and M1 protein from Streptococcus pyogenes. Mol Microbiol. 2008;67(3):482\u201392.","journal-title":"Mol Microbiol"},{"issue":"49","key":"4809_CR22","doi-asserted-by":"publisher","first-page":"31113","DOI":"10.1074\/jbc.272.49.31113","volume":"272","author":"K Balasubramanian","year":"1997","unstructured":"Balasubramanian K, Chandra J, Schroit AJ. Immune clearance of phosphatidylserine-expressing cells by phagocytes. The role of beta2-glycoprotein I in macrophage recognition. J Biolog Chem. 1997;272(49):31113\u20137.","journal-title":"J Biolog Chem."},{"issue":"1","key":"4809_CR23","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13054-021-03775-3","volume":"25","author":"Y Jiao","year":"2021","unstructured":"Jiao Y, Zhang T, Zhang C, Ji H, Tong X, Xia R, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit Care (London, England). 2021;25(1):356.","journal-title":"Crit Care (London, England)"},{"key":"4809_CR24","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.2147\/JIR.S307801","volume":"14","author":"H Pan","year":"2021","unstructured":"Pan H, Huang W, Wang Z, Ren F, Luo L, Zhou J, et al. The ACE2-ang-(1\u20137)-mas axis modulates M1\/M2 macrophage polarization to relieve CLP-induced inflammation via TLR4-mediated NF-\u043ab and MAPK pathways. J Inflamm Res. 2021;14:2045\u201360.","journal-title":"J Inflamm Res"},{"key":"4809_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2021.104475","volume":"372","author":"S Sun","year":"2022","unstructured":"Sun S, Yao Y, Huang C, Xu H, Zhao Y, Wang Y, et al. CD36 regulates LPS-induced acute lung injury by promoting macrophages M1 polarization. Cell Immunol. 2022;372: 104475.","journal-title":"Cell Immunol"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-04809-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-024-04809-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-024-04809-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T05:13:24Z","timestamp":1706591604000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-024-04809-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4809"],"URL":"https:\/\/doi.org\/10.1186\/s13054-024-04809-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3332030\/v1","asserted-by":"object"}]},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were approved by the Clinical Research Ethics Committee of Institutional Review Board of Children\u2019s Hospital of Chongqing Medical University (File No: ChiCTR-ROC-17011164 and (2022) Ethical Review Research No. 427). All animal experiments were conducted under the rules approved by the Ethics Committee of Chongqing Experimental Animal Center and the Animal Committee of Children\u2019s Hospital (CHCMU-IACUC20221227002).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All listed authors consent to the submission, and all data are used with the consent of the person generating the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors are preparing the application for Chinese patent that using of APOH in the diagnosis and potential treatment for paediatric sepsis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36"}}